IMMZD2DTMeaslesOngoingTransmissionVS vs IMMZD2DTMeaslesOngoingTransmissionVS

ValueSet Comparison between http://smart.who.int/immunizations/ValueSet/IMMZD2DTMeaslesOngoingTransmissionVS vs http://smart.who.int/immunizations/ValueSet/IMMZD2DTMeaslesOngoingTransmissionVS

Messages

Error

ValueSet.version

Values for version differ: '1.0.0' vs '0.2.0'

Information

ValueSet.date

Values for date differ: '2026-10-02T09:40:20+00:00' vs '2026-10-06T15:33:49+00:00'

Information

ValueSet.jurisdiction

Added the item 'null#null'

Metadata

Name	Value	Comments
compose.inactive
compose.lockedDate
copyright
date	2026-10-02T09:40:20+00:00	2026-10-06T15:33:49+00:00	Values Differ
description	ValueSet IMMZD2DTMeaslesOngoingTransmission for IMMZ.D2.DT.Measles.Ongoing transmission. Business rule: Determine if the client is due for a measles vaccination according to the national immunization schedule Trigger: IMMZ.D2 Determine required vaccination(s) if any Table: Countries with ongoing transmission in which the risk of measles mortality remains high (countries that provide first dose of measles-containing vaccine (MCV) at 9 months and second dose of MCV at 15 months)
experimental
immutable
jurisdiction
jurisdiction[0]		null#null	Added the item 'null#null'
name	IMMZD2DTMeaslesOngoingTransmissionVS
publisher	WHO
purpose
status	active
title	IMMZD2DTMeaslesOngoingTransmission ValueSet for Decision Table
url	http://smart.who.int/immunizations/ValueSet/IMMZD2DTMeaslesOngoingTransmissionVS
version	1.0.0	0.2.0	Values Differ

Name

Value

Comments

compose.inactive

compose.lockedDate

date

2026-10-02T09:40:20+00:00

2026-10-06T15:33:49+00:00

Values Differ

description

ValueSet IMMZD2DTMeaslesOngoingTransmission for IMMZ.D2.DT.Measles.Ongoing transmission. Business rule: Determine if the client is due for a measles vaccination according to the national immunization schedule Trigger: IMMZ.D2 Determine required vaccination(s) if any Table: Countries with ongoing transmission in which the risk of measles mortality remains high (countries that provide first dose of measles-containing vaccine (MCV) at 9 months and second dose of MCV at 15 months)

experimental

immutable

jurisdiction

jurisdiction[0]

null#null

Added the item 'null#null'

name

IMMZD2DTMeaslesOngoingTransmissionVS

publisher

WHO

purpose

status

active

title

IMMZD2DTMeaslesOngoingTransmission ValueSet for Decision Table

url

http://smart.who.int/immunizations/ValueSet/IMMZD2DTMeaslesOngoingTransmissionVS

version

1.0.0

0.2.0

Values Differ

Definition

Item	Property	Value
include	http://smart.who.int/immunizations/CodeSystem/IMMZDAK
Concept	Client's age is less than 9 months-41	Client's age is less than 9 months
Concept	Client is not due for first dose of measles-containing vaccine (MCV1)-48	Client is not due for first dose of measles-containing vaccine (MCV1)
Concept	No measles primary series doses were administered-127	No measles primary series doses were administered
Concept	Client's age is more than or equal to 9 months-41	Client's age is more than or equal to 9 months
Concept	No live vaccine was administered in the last 4 weeks-92	No live vaccine was administered in the last 4 weeks
Concept	Client is due for MCV1-44	Client is due for MCV1
Concept	Live vaccine was administered in the last 4 weeks-92	Live vaccine was administered in the last 4 weeks
Concept	Client is not due for MCV1-48	Client is not due for MCV1
Concept	MCV1 was administered-127	MCV1 was administered
Concept	Client's age is less than 15 months-42	Client's age is less than 15 months
Concept	Client is not due for second dose of measles-containing vaccine (MCV2)-48	Client is not due for second dose of measles-containing vaccine (MCV2)
Concept	Client's age is more than or equal to 15 months-42	Client's age is more than or equal to 15 months
Concept	Client is due for MCV2-44	Client is due for MCV2
Concept	Client is not due for MCV2-48	Client is not due for MCV2
Concept	MCV2 was administered-127	MCV2 was administered
Concept	Measles primary series is complete-104	Measles primary series is complete

Item

Property

Value

Comments

include

http://smart.who.int/immunizations/CodeSystem/IMMZDAK

Concept

Client's age is less than 9 months-41

Client's age is less than 9 months

Concept

Client is not due for first dose of measles-containing vaccine (MCV1)-48

Client is not due for first dose of measles-containing vaccine (MCV1)

Concept

No measles primary series doses were administered-127

No measles primary series doses were administered

Concept

Client's age is more than or equal to 9 months-41

Client's age is more than or equal to 9 months

Concept

No live vaccine was administered in the last 4 weeks-92

No live vaccine was administered in the last 4 weeks

Concept

Client is due for MCV1-44

Client is due for MCV1

Concept

Live vaccine was administered in the last 4 weeks-92

Live vaccine was administered in the last 4 weeks

Concept

Client is not due for MCV1-48

Client is not due for MCV1

Concept

MCV1 was administered-127

MCV1 was administered

Concept

Client's age is less than 15 months-42

Client's age is less than 15 months

Concept

Client is not due for second dose of measles-containing vaccine (MCV2)-48

Client is not due for second dose of measles-containing vaccine (MCV2)

Concept

Client's age is more than or equal to 15 months-42

Client's age is more than or equal to 15 months

Concept

Client is due for MCV2-44

Client is due for MCV2

Concept

Client is not due for MCV2-48

Client is not due for MCV2

Concept

MCV2 was administered-127

MCV2 was administered

Concept

Measles primary series is complete-104

Measles primary series is complete

Expansion

Unable to generate expansion - see errors